Cargando…

Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study

BACKGROUND: In trials evaluating perioperative chemotherapy for gastric cancer, which serve as the basis for treatment guidelines, patients are selected. The generalizability of these trial findings to older patients is uncertain. METHODS: This population-based retrospective cohort study compared th...

Descripción completa

Detalles Bibliográficos
Autores principales: Keywani, Kammy, Borgstein, Alexander B. J., Eshuis, Wietse J., Pape, Marieke, Versteeg, Kathelijn S., Derks, Sarah, van Laarhoven, Hanneke W. M., Gisbertz, Suzanne S., Verhoeven, Rob H. A., van Berge Henegouwen, Mark I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361849/
https://www.ncbi.nlm.nih.gov/pubmed/37285071
http://dx.doi.org/10.1007/s10120-023-01404-2
_version_ 1785076298755866624
author Keywani, Kammy
Borgstein, Alexander B. J.
Eshuis, Wietse J.
Pape, Marieke
Versteeg, Kathelijn S.
Derks, Sarah
van Laarhoven, Hanneke W. M.
Gisbertz, Suzanne S.
Verhoeven, Rob H. A.
van Berge Henegouwen, Mark I.
author_facet Keywani, Kammy
Borgstein, Alexander B. J.
Eshuis, Wietse J.
Pape, Marieke
Versteeg, Kathelijn S.
Derks, Sarah
van Laarhoven, Hanneke W. M.
Gisbertz, Suzanne S.
Verhoeven, Rob H. A.
van Berge Henegouwen, Mark I.
author_sort Keywani, Kammy
collection PubMed
description BACKGROUND: In trials evaluating perioperative chemotherapy for gastric cancer, which serve as the basis for treatment guidelines, patients are selected. The generalizability of these trial findings to older patients is uncertain. METHODS: This population-based retrospective cohort study compared the survival outcomes of patients ≥ 75 years with gastric adenocarcinoma treated with or without neoadjuvant chemotherapy between 2015 and 2019. Additionally, the percentage of patients < 75 years and ≥ 75 years who did not proceeded to surgery after receiving neoadjuvant chemotherapy were examined. RESULTS: A total of 1995 patients, of whom 1249 aged < 75 years and 746 aged ≥ 75 years, were included. In the group of patients ≥ 75 years, 275 patients received neoadjuvant chemotherapy and 471 patients were directly scheduled for gastrectomy. Patients ≥ 75 years treated with or without neoadjuvant chemotherapy differed significantly from one and another in characteristics. Overall survival of patients ≥ 75 years treated with or without neoadjuvant chemotherapy was not significantly different (median 34.9 vs. 32.3 months; P = 0.506), also after adjusting for potential confounders (HR 0.87; P = 0.263). Of patients ≥ 75 years who received neoadjuvant chemotherapy, 43 (15.6%) did not proceed to surgery compared to 111 (8.9%) patients < 75 years (P < 0.001). CONCLUSION: Patients ≥ 75 years treated with or without chemotherapy were highly selected, and overall survival was not significantly different between both groups. Nonetheless, the proportion of patients who did not proceed to surgery following neoadjuvant chemotherapy was higher in patients ≥ 75 years compared to patients < 75 years. Therefore, neoadjuvant chemotherapy should be considered with more caution in patients ≥ 75 years, while identifying those who may benefit. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10120-023-01404-2.
format Online
Article
Text
id pubmed-10361849
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-103618492023-07-23 Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study Keywani, Kammy Borgstein, Alexander B. J. Eshuis, Wietse J. Pape, Marieke Versteeg, Kathelijn S. Derks, Sarah van Laarhoven, Hanneke W. M. Gisbertz, Suzanne S. Verhoeven, Rob H. A. van Berge Henegouwen, Mark I. Gastric Cancer Original Article BACKGROUND: In trials evaluating perioperative chemotherapy for gastric cancer, which serve as the basis for treatment guidelines, patients are selected. The generalizability of these trial findings to older patients is uncertain. METHODS: This population-based retrospective cohort study compared the survival outcomes of patients ≥ 75 years with gastric adenocarcinoma treated with or without neoadjuvant chemotherapy between 2015 and 2019. Additionally, the percentage of patients < 75 years and ≥ 75 years who did not proceeded to surgery after receiving neoadjuvant chemotherapy were examined. RESULTS: A total of 1995 patients, of whom 1249 aged < 75 years and 746 aged ≥ 75 years, were included. In the group of patients ≥ 75 years, 275 patients received neoadjuvant chemotherapy and 471 patients were directly scheduled for gastrectomy. Patients ≥ 75 years treated with or without neoadjuvant chemotherapy differed significantly from one and another in characteristics. Overall survival of patients ≥ 75 years treated with or without neoadjuvant chemotherapy was not significantly different (median 34.9 vs. 32.3 months; P = 0.506), also after adjusting for potential confounders (HR 0.87; P = 0.263). Of patients ≥ 75 years who received neoadjuvant chemotherapy, 43 (15.6%) did not proceed to surgery compared to 111 (8.9%) patients < 75 years (P < 0.001). CONCLUSION: Patients ≥ 75 years treated with or without chemotherapy were highly selected, and overall survival was not significantly different between both groups. Nonetheless, the proportion of patients who did not proceed to surgery following neoadjuvant chemotherapy was higher in patients ≥ 75 years compared to patients < 75 years. Therefore, neoadjuvant chemotherapy should be considered with more caution in patients ≥ 75 years, while identifying those who may benefit. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10120-023-01404-2. Springer Nature Singapore 2023-06-07 2023 /pmc/articles/PMC10361849/ /pubmed/37285071 http://dx.doi.org/10.1007/s10120-023-01404-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Keywani, Kammy
Borgstein, Alexander B. J.
Eshuis, Wietse J.
Pape, Marieke
Versteeg, Kathelijn S.
Derks, Sarah
van Laarhoven, Hanneke W. M.
Gisbertz, Suzanne S.
Verhoeven, Rob H. A.
van Berge Henegouwen, Mark I.
Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
title Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
title_full Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
title_fullStr Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
title_full_unstemmed Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
title_short Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
title_sort neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361849/
https://www.ncbi.nlm.nih.gov/pubmed/37285071
http://dx.doi.org/10.1007/s10120-023-01404-2
work_keys_str_mv AT keywanikammy neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT borgsteinalexanderbj neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT eshuiswietsej neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT papemarieke neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT versteegkathelijns neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT derkssarah neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT vanlaarhovenhannekewm neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT gisbertzsuzannes neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT verhoevenrobha neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy
AT vanbergehenegouwenmarki neoadjuvantchemotherapyinolderpatientswithgastriccancerundergoingsurgeryapopulationbasedcohortstudy